Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells

被引:62
作者
Travers, MT [1 ]
Gow, IF [1 ]
Barber, MC [1 ]
Thomson, J [1 ]
Shennan, DB [1 ]
机构
[1] Hannah Res Inst, Ayr KA6 5HL, Scotland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2004年 / 1661卷 / 01期
关键词
indoleamine 2,3-dioxygenase; tryptophan transport; breast cancer;
D O I
10.1016/j.bbamem.2003.12.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activity and expression of indoleamine 2,3-dioxygenase together with L-tryptophan transport has been examined in cultured human breast cancer cells. MDA-MB-231 but not MCF-7 cells expressed mRNA for indoleamine 2,3-dioxygenase. Kynurenine production by MDA-MB-231 cells, which was taken as a measure of enzyme activity, was markedly stimulated by interferon-gamma (1000 units/ml). Accordingly, L-tryptophan utilization by MDA-MB-231 cells was enhanced by interferon-gamma. 1-Methyl-DL-tryptophan (1 mM) inhibited interferon-gamma induced kynurenine production by MBA-MB-231 cells. Kynurenine production by MCF-7 cells remained at basal levels when cultured in the presence of interferon-gamma. L-Tryptophan transport into MDA-MB-231 cells was via a Na+-independent, BCH-sensitive pathway. It appears that system L (LAT1/CD98) may be the only pathway for L-tryptophan transport into these cells. 1-Methyl-D,L-tryptophan trans-stimulated L-tryptophan efflux from MDA-MB-231 cells and thus appears to be a transported substrate of system L. The results suggest that system L plays an important role in providing indoleamine-2,3-dioxygenase with its main substrate, L-tryptophan, and suggest a mechanism by which estrogen receptor-negative breast cancer cells may evade the attention of the immune system. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 24 条
[1]   1-METHYL-DL-TRYPTOPHAN, BETA-(3-BENZOFURANYL)-DL-ALANINE (THE OXYGEN ANALOG OF TRYPTOPHAN), AND BETA-[3-BENZO(B)THIENYL]-DL-ALANINE (THE SULFUR ANALOG OF TRYPTOPHAN) ARE COMPETITIVE INHIBITORS FOR INDOLEAMINE 2,3-DIOXYGENASE [J].
CADY, SG ;
SONO, M .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 291 (02) :326-333
[2]   INTERFERONS AND INDOLEAMINE 2,3-DIOXYGENASE - ROLE IN ANTIMICROBIAL AND ANTITUMOR EFFECTS [J].
CARLIN, JM ;
OZAKI, Y ;
BYRNE, GI ;
BROWN, RR ;
BORDEN, EC .
EXPERIENTIA, 1989, 45 (06) :535-541
[3]  
DAVIS LG, 1986, BASIC METHODS MOL BI, P143
[4]   T cell apoptosis by tryptophan catabolism [J].
Fallarino, I ;
Grohmann, U ;
Vacca, C ;
Bianchi, R ;
Orabona, C ;
Spreca, A ;
Fioretti, MC ;
Puccetti, P .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (10) :1069-1077
[5]   Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection [J].
Friberg, M ;
Jennings, R ;
Alsarraj, M ;
Dessureault, S ;
Cantor, A ;
Extermann, M ;
Mellor, AL ;
Munn, DH ;
Antonia, SJ .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (02) :151-155
[6]   Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase [J].
Frumento, G ;
Rotondo, R ;
Tonetti, M ;
Damonte, G ;
Benatti, U ;
Ferrara, GB .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (04) :459-468
[7]   Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) [J].
Kanai, Y ;
Segawa, H ;
Miyamoto, K ;
Uchino, H ;
Takeda, E ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :23629-23632
[8]   Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection [J].
Kudo, Y ;
Boyd, CAR .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1500 (01) :119-124
[9]   Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia [J].
Kudo, Y ;
Boyd, CAR ;
Sargent, IL ;
Redman, CWG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) :719-726
[10]   The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants [J].
Kudo, Y ;
Boyd, CAR .
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 531 (02) :417-423